NLS Global report

Acquisition - April 7, 2026

MSD to acquire Terns Pharmaceuticals

MSD and Terns Pharmaceuticals have entered into a definitive agreement under which MSD, through a subsidiary, will acquire Terns for an approximate equity value of USD 6.7 billion.

Global report - April 6, 2026

Flanders punches above its weight in European biotech

The Belgian region of Flanders has long been one of Europe’s most industrially dynamic regions. Its economy is anchored by advanced manufacturing, logistics, and a life science sector that consistently performs far above the region’s size.

Acquisition - April 1, 2026

Eli Lilly and Company to acquire Centessa Pharmaceuticals

Centessa is advancing a pipeline of orexin receptor 2 (OX2R) agonists designed to address the neurobiological system critical to the sleep-wake cycle to treat excessive daytime sleepiness and disorders of impaired wakefulness.

Acquisition - April 1, 2026

Biogen to acquire Apellis Pharmaceuticals

The two companies have entered into a definitive agreement under which Biogen has agreed to acquire all outstanding shares of Apellis for USD 41.00 per share in cash at closing, or approximately USD 5.6 billion.

Acquisition - March 30, 2026

Insilico Medicine and Lilly enter R&D collaboration

Insilico Medicine has announced a drug discovery collaboration with Eli Lilly and Company (Lilly) that uses Insilico’s AI engine to accelerate the discovery and development of novel therapeutics across multiple therapeutic areas.

Global report - March 30, 2026

Scientists Fighting Back

Many observers and most of the scientific community agree; the outlook for scientific research in the US has never been more uncertain.

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.